Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kigelia africana stem bark extract
- Development stage
- Preclinical
- Lead developer
- University of Buea
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Topical
01
Overview
Kigelia africana stem bark extract is a crude botanical preparation derived from the stem bark of *Kigelia africana* (commonly known as the sausage tree). It is a complex, multi-component natural product traditionally used in African folk medicine to treat various ailments, including skin diseases, sores, ulcers, stomach problems, and gynecological complaints. Preclinical research has demonstrated that the extract possesses antimicrobial, antioxidant, anti-inflammatory, analgesic, wound-healing, and antidiabetic properties. Additionally, it has shown cytotoxic activity against several cancer cell lines, including lung adenocarcinoma (A549), breast cancer (HCC 1937), and leukemia models. Active constituents identified within the extract include quinones such as lapachol, 2-(1-hydroxyethyl)-2-acetylnaphtho[2,3-b]furan-4,9-dione, and 2-acetylnaphtho[2,3-b]furan-4,9-dione. It is currently investigated as a research material and has no established single molecular target or commercial developer.
- Other names
- Kigelia africana stembark extractKigelia pinnata stem bark extract
Beyond the preview
Go deeper on Kigelia africana stem bark extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kigelia africana stem bark extract.